全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

A Case of Euglycemic Diabetic Ketoacidosis in Patient with Type 2 DM

DOI: 10.4236/ojem.2023.114017, PP. 174-179

Keywords: Euglycemic DKA, Glucose Level, Acidosis

Full-Text   Cite this paper   Add to My Lib

Abstract:

Diabetic ketoacidosis (DKA) can cause significant morbidity and mortality in patient with both type 1 and type 2 diabetes mellitus. A subset of DKA cases termed euglycemic diabetic ketoacidosis (EDKA) is characterized by euglycemic (<200 mg/dl), high anion gap metabolic acidosis, and increased plasma ketone concentration. This clinical syndrome is primary related to a general state of starvation, resulting in the development of ketosis while maintaining normoglycemia. It can lead to severe complication, such as extreme dehydration, altered mental status and coma. Early recognition and treatment are essential to avoid this life-threatening complication. EDKA represents approximately 2.6% to 3.2% of total DKA admissions, making it a rare condition. In this case report, a male patient was diagnosed with type 2 DM, 1 week prior to his symptoms and admission in hospital. Despite normal glucose levels at the time of presentation to the ED, he displayed severe acidemia and ketonemia, and was diagnosed with EDKA.

References

[1]  Plewa, M.C. (2023, January 29) Euglycemic Diabetic Ketoacidosis. StatPearls—NCBI Bookshelf.
https://www.ncbi.nlm.nih.gov/books/NBK554570/
[2]  Munro, J., Iw, C., McCuish, A.C. and Duncan, L.J.P. (1973) Euglycaemic Diabetic Ketoacidosis. BMJ, 2, 578-580.
https://doi.org/10.1136/bmj.2.5866.578
[3]  Jenkins, D., Close, C., Krentz, A., Nattrass, M. and Wright, A. (1993) Euglycaemic Diabetic Ketoacidosis: Does It Exist? Acta Diabetologica, 30, 251-253.
https://doi.org/10.1007/BF00569937
[4]  Long, B., Lentz, S., Koyfman, A. and Gottlieb, M. (2021) Euglycemic Diabetic Ketoacidosis: Etiologies, Evaluation, and Management. American Journal of Emergency Medicine, 44, 157-160.
https://doi.org/10.1016/j.ajem.2021.02.015
[5]  Yu, X., Zhang, S. and Zhang, L. (2018) Newer Perspectives of mechanisms for euglycemic Diabetic Ketoacidosis. International Journal of Endocrinology, 2018, Article ID: 7074868.
https://doi.org/10.1155/2018/7074868
[6]  Nasa, P., Chaudhary, S., Shrivastava, P.K. and Singh, A. (2021) Euglycemic Diabetic Ketoacidosis: A Missed Diagnosis. World Journal of Diabetes, 12, 514-523.
https://doi.org/10.4239/wjd.v12.i5.514
[7]  Diaz-Ramos, A., Eilbert, W. and Márquez, D. (2019) Euglycemic Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter-2 Inhibitor Use: A Case Report and Review of the Literature. International Journal of Emergency Medicine, 12, Article No. 27.
https://doi.org/10.1186/s12245-019-0240-0
[8]  Peters, A.L., Buschur, E., Buse, J.B., Cohan, P., Diner, J. and Hirsch, I.B. (2015) Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment with Sodium-Glucose Cotransporter 2 Inhibition. Diabetes Care, 38, 1687-1693.
https://doi.org/10.2337/dc15-0843
[9]  Blau, J., Tella, S.H., Taylor, S.I. and Rother, K.I. (2017) Ketoacidosis Associated with SGLT2 Inhibitor Treatment: Analysis of FAERS Data. Diabetes-Metabolism Research and Reviews, 33, e2924.
https://doi.org/10.1002/dmrr.2924
[10]  Jazi, M. and Porfiris, G. (2016) Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Treated with a Sodium-Glucose Cotransporter-2 Inhibitor. Canadian Family Physician, 62, 722-724.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844559/

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133